We serve Chemical Name:1-(1-Adamantyl)-2-bromopropan-1-one CAS:26525-24-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(1-Adamantyl)-2-bromopropan-1-one
CAS.NO:26525-24-6
Synonyms:F0266-0294;1-Adamantyl-1-bromethyl-keton;1-Adamantan-1-yl-2-bromo-propan-1-one
Molecular Formula:C13H19BrO
Molecular Weight:271.19300
HS Code:2914700090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:329.1ºC at 760mmHg
Density:1.387g/cm3
Index of Refraction:1.564
PSA:17.07000
Exact Mass:270.06200
LogP:3.55530
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like F0266-0294 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Adamantan-1-yl-2-bromo-propan-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Adamantyl-1-bromethyl-keton Use and application,1-Adamantan-1-yl-2-bromo-propan-1-one technical grade,usp/ep/jp grade.
Related News: GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. 1-(1-Adamantyl)-2-bromopropan-1-one manufacturer We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally. 1-(1-Adamantyl)-2-bromopropan-1-one supplier Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. 1-(1-Adamantyl)-2-bromopropan-1-one vendor Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 1-(1-Adamantyl)-2-bromopropan-1-one factory GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.
